Novel microtubule-associated protein for drought-tolerant crop development

Technology
In development
University

A novel microtubule-associated protein (MAP) that, when overexpressed, increases crop yield under water scarcity by enhancing leaf and stem thickness through additional mesophyll cell layers. Validated in Arabidopsis and Camelina sativa, offering a new approach to drought tolerance distinct from conventional regulatory or metabolic pathway targets.

Overview

This innovation centers on a novel microtubule-associated protein (MAP) whose overexpression in plants produces thicker leaves and stems, conferring improved drought tolerance and increased yield under water-limited conditions. Unlike conventional drought-tolerance strategies that target regulatory proteins or metabolic pathways, this MAP acts predominantly during plant development, increasing mesophyll cell layers and parenchyma cell numbers. The resulting morphology gives plants a succulent appearance and improved water-use efficiency.

Validated in the model plant Arabidopsis thaliana and the oilseed crop Camelina sativa, the technology has demonstrated consistent morphological and physiological benefits. Transgenic Camelina lines showed increased stem circumference and approximately 30% greater leaf thickness due to additional mesophyll cell layers. Under controlled glasshouse drought conditions, transgenic plants survived significantly longer than wild-type plants after watering was stopped, demonstrating the practical viability of this approach for improving crop resilience to water scarcity.

Technical specifications

Key features:

  • Novel microtubule-associated protein that modulates plant developmental architecture
  • Overexpression leads to increased mesophyll cell layers, producing thicker leaves
  • Enhanced parenchyma cell numbers contribute to greater stem thickness
  • Morphological changes confer a succulent phenotype that improves water retention
  • Mechanism is distinct from traditional regulatory or metabolic pathway approaches
  • Demonstrated efficacy in both Arabidopsis thaliana and Camelina sativa

Validation results:

  • Transgenic Camelina sativa lines confirmed phenotypic traits matching Arabidopsis results
  • Glasshouse drought trials showed transgenic lines survived 11+ days without water while wild-type plants wilted
  • DEFRA approval granted for field testing at Rothamsted Research
Technology readiness level

The technology is currently at an advanced validation stage. Laboratory and glasshouse validation have been completed in two plant species, confirming both the morphological changes and drought-tolerance benefits. A planned field trial from April/May to September 2021 at Rothamsted Research represents the critical next step toward commercial validation. This field trial, conducted under natural precipitation conditions, will assess whether the drought-tolerance trait translates to real-world agricultural environments. The technology is positioned for partnership with seed companies, agricultural biotech firms, and crop improvement programs seeking novel drought-tolerance traits for commercial crop development.


About Rothamsted Research

Rothamsted Research is a multi‑site national agricultural research institute headquartered in Harpenden, UK, combining discovery science with field‑ and farm‑scale experimentation. Co‑located long‑term experimental fields and a 330‑hectare research farm enable controlled trials, while the North Wyke Farm Platform provides an instrumented, commercial‑scale farm lab for systems testing and validation. An on‑site agri‑tech campus operated by Rothamsted Enterprises offers labs, trial land, and flexible space for partners, fostering co‑location with researchers and rapid iteration from lab to field. Research is principally supported by UKRI’s Biotechnology and Biological Sciences Research Council, with additional competitive awards and national research‑infrastructure support.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.